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1. Introduction 
The human placenta contains a soluble 1 5S-hydroxy 
prostaglandin dehydrogenase (EC 1.1.1.141) which is 
the first enzyme involved in the catabolism of pro- 
staglandins in the placenta [ 11. A strict stereospecificity 
for the 15S-hydroxy group of prostaglandin is a 
characteristic feature of this enzyme which accepts 
only NAD’ as cofactor [2]. The reverse reaction, 
reduction of the 15ketoprostaglandin in the presence 
of NADH is possible in vitro (31. This property 
enabled us to study the stereospecificity of hydrogen 
transfer by the 15 hydroxy prostaglandin dehydroge- 
nase. 
When tritium is transferred by a dehydrogenase 
from a substrate to the carbon atom C4 of NAD’, a 
4 R or 4 S configuration appears depending on the 
stereospeciticity of the enzyme [4]. Class A dehydro- 
genases lead to the 4 R configuration, class B dehydro- 
genases to the 4 S configuration [5]. In the present 
experiment, 15-keto-PGEs was incubated with the 
enzyme in the presence of 4 S [4-3H]NADH: only the 
tritium was transferred to the prostaglandin. Thus, 
our data give evidence that human placental pro- 
staglandin dehydrogenase mediates hydrogen transfer 
from the 4-pro-S side of NADH to the substrate and 
should be considered as a B enzyme. 
2. Materials and methods 
2.1. Preparation of the enzyme 
The placental cytosol was prepared as previously 
described [6] and the purification was carried out in 
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potassium phosphate buffer, pH 7.2, 10V3 M EDTA, 
0.01 M /3-mercaptoethanol and 20% glycerol; only 
the potassium phosphate concentration varied during 
the following chromatographies: 
(1) DEAE-cellulose (Whatman DE 23) (4 X 15 cm), 
elution with a linear gradient between 300 ml 0.03 M, 
and 300 ml 0.1 M, phosphate. 
(2) Ecteola (Cellex E) (2.5 X 15 cm), elution with a 
gradient between 0.003 M and 0.06 M phosphate. 
(3) Hydroxyapatite (1.5 X 50 cm), elution with a 
gradient between 0.01 M and 0.06 M phosphate. 
(4) GlOO Sephadex gel filtration (5 X 120 cm) 
equilibrated in 0.03 M phosphate. 
The elution gradients of the Ecteola and hydroxy- 
apatite chromatographies were established by using 
an Ultrograd LKB apparatus; the shape of the gradient 
was checked in order to achieve complete elimination 
of the estradiol dehydrogenase activity. 
2.2. Incubations 
Enzymatic oxidation of PGEr was carried out at 
25°C with 0.6 pmol NAD’, 0.056 ymol [5,6-3H]PGEI 
(2.4 X 10’ dpm) (the Radiochemical Centre Ltd, 
Amersham), 0.5 unit of purified enzyme in 0.1 M 
phosphate buffer, pH 8.1, to a final volume of 1 ml. 
Enzymatic reduction of 1 5-keto-PGE2 was perform- 
ed with 0.6 pmol NADH, 0.06 pmol of 15-keto-PGE*, 
0.5 unit of purified enzyme in 0.1 M phosphate buffer, 
pH = 7.2, to a final volume of 1 ml. 
The reaction products were extracted by ethyl 
acetate and analysed by thin layer chromatography 
with chloroform/methanol/acetic acid (90 : 5 : 5, 
v/v/v) as the irrigant with standard prostaglandins as 
references. Zones corresponding to the radioactive 
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peaks (detected by a Panax radiochromatogram 
Scanner) were scraped into counting vials containing 
15 ml of scintillation mixture (3 g diphenyl oxazole/l 
toluene) and assayed for radioactivity by liquid 
scintillation counting. 
2.3. Preparation of 4 S/4-3HJNADH 
NADH labelled with 3H in 4 S position was prepared 
from [4-3H] NAD+(the Radiochemical Centre Amersham; 
specific radioactivity 2.7 X lo7 dpm/pmol) by reduc- 
tion in the presence of ethanol and liver alcohol 
dehydrogenase (A enzyme) [7]. The incubation mix- 
ture contained 1 ml of ethanol, 1 mg of horse liver 
alcohol dehydrogenase 4.5 pmol [4-3H]NAD’ and 
0.1 M Tris-HCl buffer pH 9.5 to a final volume of 
10 ml. The incubation was run at 25°C; the reaction 
recorded at 340 nm was terminated by heating at 
70°C for 5 min. The remaining [4-3H]NAD’ was 
separated from 4 S [4-3 H] NADH by DEAE-cellulose 
chromatography according to 181. The elution was 
followed by the absorbance at 260 mn and 340 nm; 
radioactivity was quantified on 50 ~1 aliquots of each 
fraction. 
2.4. Verification of the 4 S [4-3H/NADH and con- 
figuration 
Two enzymatic procedures were used: 
(1) Reduction of Na pyruvate by 4 S [4-3H]NADH 
and lactate dehydrogenase (A enzyme). The incuba- 
tion mixture contained 2.8 gmol of pyruvate, 
0.19 pmol of 4 S [4-3H]NADH (4.8 X lo6 dpm), 
40 pg of lactate dehydrogenase and 0.1 M phosphate 
buffer, pH = 7.,, 3 in a final volume of 3 ml. A control 
was run without enzyme. The mixture was incubated 
for one hour at 25°C. The reduction was stopped by 
immersion in boiling water for 2 min 0.3 pmol of 
carrier lactate were added to aliquots of each reaction 
mixture (0.2 ml), the products were chromatographed 
on Whatman No. 1 paper and identified as described 
in [9]. The paper areas corresponding to NAD* and 
lactate were burnt in an Oxymat apparatus and the 
radioactivity was measured by liquid scintillation 
counting. 
(2) Reduction of oestrone using 4 S [4-3H]NADH 
and the placental estradiol dehydrogenase (B enzyme). 
The incubation mixture contained 0.3 pmol of estrone, 
0.38 pmol of 4 S [4-jH] NADH (9.6 X 1 O6 dpm), 
100 4 of estradiol dehydrogenase (specific activity = 
4 U/mg) [IO] and 0.1 M Tris-HCl buffer, pH = 7.2, 
with BSA 3% in a final volume of 3 ml. After a one 
hour incubation at 25°C the remaining estrone and 
the estradiol formed were extracted by chloroform, 
chromatographed in the chloroform-acetone system 
(9 : 1, v/v). The estradiol spot was scraped off, 
extracted and the radioactivity was measured as 
described in 2.2. 
2.5. Reduction of I5-keto-PGE2 using 4 S/4-3H] 
NADH and IS-hydroxy-prostaglandin dehydro- 
genase 
The incubation mixture contained 0.28 pmol of 
15-keto-PGE*, 0.38 pmol of 4 S [4-3H]NADH 
(specific radioactivity = 2.55 X lo7 dpm/fimol), 1 unit 
of hydroxyprostaglandin dehydrogenase and 0.1 M 
Tris-HCl buffer, pH = 7.2, to a final volume of 3 ml. 
The incubations were run a! 25°C. The reaction was 
followed spectrophotometrically at 340 nm. Controls 
were run without enzyme. The reaction products 
were extracted and analysed as described in (2.2.). 
The radioactivity was measured on aliquots of both 
the aqueous and the organic phases. The PGEZ spot 
localized on the thin-layer chromatography plate 
after the run was eluted by methanol, and aliquots 
were counted for radioactivity. 
2.6. Oxidation of (15-3H]PGEz using NAD’ and 
IS-hydroxy-prostaglandin dehydrogenase 
The [ 1 5-3H]PGE2 synthetized as described in 
paragraph 2.5. was diluted with unlabelled PGEz and 
the oxidation reaction was carried out in the con- 
ditions described in (2.2.). A reference test was run 
without enzyme. 
3. Results and comments 
3.1. firity of the 15-hydroxy-prostaglandin dehydm 
genase preparation 
The specific activity of the enzyme preparation 
was 4 U/mg. in spite of this high specific activity, 
homogeneity was not achieved, since three protein 
discs were observed on acrylamide gel electrophoresis. 
However, the purified enzyme was devoid of any 
enzymatic activity which could interfere with the 
oxidation of the 4 S [4-jH] NADH used in the hydrogen 
transfer experiments: PGEz was the only product 
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Fig.1. Reduction of IS-keto-PGE, by NADH and purified 
15hydroxy-prostaglandin dehydrogenase. After incubation 
and extraction the products were analysed by thin-layer 
chromato~aphy as described in paragraph 2.2. E = IS-keto- 
PGE, + NADH + enzyme. C = control without enzyme. 
Reference products: 1 = PGE,, 2 = 15-keto-PGE,, 3 = PGF,o, 
4 = 15keto-13,14-dihydro-PGE,. 
formed when 15keto-PGEa was reduced by the 
enzyme preparation in the conditions described in 
(2.2.). The thin-layer chromatography of the extrac- 
tion products (fig. 1) shows that neither products of 
the 9.ketoreductase nor products of the A 13 reductase 
(NADH dependent enzymes) were detected. 
Moreover, when [ 5$L3H] PGEr was incubated with 
1 S-hydroxy-prostaglandin dehydrogenase and NAD’, 
less than 3% of radioactivity was found in the 15keto- 
13,14-dihydro_PGEr fraction. This radioactivity was 
certainly due to a conta~nation by the very close 
15keto-PGE, fraction rather than to the actual 
presence of 15-keto-13,1Cdihydro-PGEl (table 1). 
The activity of A 13 reductase would have given large 
amounts of 15-keto-13,1Cd&ydro-PGEr since the 
oxidation of PGEr gave stoichiometric quantities of 
NADH. 
3.2. Purity of the 4 S[4-3HJ~A~H 
The enzymatic reduction of [4-3H]NAD’in the 
presence of liver alcohol dehydrogenase gave 4 S 
[4-jH] NADH with a 75% a yield; after purification 
the specific radioactivity was 2.55 X 10’ dpm~~mol. 
The configuration of the carbon atom C4 was 
checked enzymatically: the coenzyme was used as a 
cofactor in the reduction of pyruvate by lactico- 
dehydrogenase and of estrone by estradiol dehydxo- 
genase in conditions described in paragraph 2.4. A 
66% oxidation of tritiated NADH (3.45 X 1 O6 dpm) 
was operated by pyruvate and lactic0 dehydrogenase 
with complete retention of tritium on the coenzyme. 
No radioactivity could be detected in the lactate 
formed. When estrone was reduced by tritiated NADH 
(7.4 X 1 O6 dpm) in the presence of estradiol dehydro- 
genase, 40% of the recovered tritium was incorporated 
into estradio] while 60% remained in the non oxidized 
coenzyme; they correspond to the excess of NADH 
owing to the stoichiometry of the reaction in the 
conditions used. 
Since estradiol dehydrogenase of human placenta 
was demonstrated to be a B enzyme [I 1 ,I 21, and 
lacticodehydrogenase to be an A enzyme [ 131, the 
configuration of the tritiated NADH that we obtained 
should be 4 S [4-3H]. 
3.3. Stereospecificity of the hydrogen transfer from 
coenzyme to substrate catalysed by 15hydroxy- 
prostaglandin dehydrogenase 
After incubation of 4 S [4-3H] NADH with 15-keto- 
PGEz and the enzyme, approximately 98% of the 
radioactivity of the organic extract was found to have 
the same migration as PGEz in thin-layer chromato- 
graphy (table 2). Assu~ng from the spectrophoto- 
metric assay of the [4-3H]NADH that 0.164 ~01 of 
Table 1 
Oxidation of [5,6-3H]PGE, by NAD+and 15-hydroxy-prostaglandin dehydrogenase 
1 S-Hydroxy- 
prostaglandin 
dehydrogenase 
[5,6-‘H]PGE, 
and NAD+ 
Distribution of radioactivity (dpm) % Radio- 
activity 
]5,6-3H]PGE, 15keto-PGE, 15keto-13,14- extracted 
diiydro PGE, 
0 + 150 000 0 0 61 
+ + 3 900 160 000 4 700 67 
After incubation and extraction, the products were separated by thin-layer chromatography and the radio- 
activity was measured in the respective fractions. 
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Reduction of 15keto-PGE, by 4 S [4-sH]NADH and 15-hydroxy-prostaglandin dehydrogenase 
15-Hydroxy- 
prostaglandin 
dehydrogenase 
15-Keto-PGE, and Radioactivity after extraction (dpm) Radioactivity 
4 S [4-‘H]NADH recovered as 
Aqueous phase Organic phase [15-3H]PGE, 
(dpm) 
0 t 7 x lo6 0 x 106 0 
+ + 3.6 x lo6 4.1 x 106 3.9 x lo6 , 
t t 3.35 x lo6 3.93 x 10’ 3.9 x lo6 
aSpecific activity 2.5 X 10’ dpm/rmol 
Distribution of the radioactivity after extraction and purification by thin-layer chromatography. 
the coenzyme were oxidized during the incubation 
time, according to the stoichiometry of the reaction 
4.18 X 1 O6 dpm should have been recovered in the 
1 5-3H-PGEa extracts. Table 2 shows that the experi- 
mental data are in good agreement with these calcuia- 
tions. 
These results indicate that the 1 S-hydroxy-pro- 
staglandin dehydrogenase transfer the [4-3H] of 4 S 
[4-3H]NADH with a stereospecificity higher than 90% 
and thus, the 1 ~I-~H-PGE~ obtained should have nearly 
the same specific radioactivity as the 4 S [4-3H] NADH 
used for the incubation. 
this product was formed from PGEa during the extrac- 
tion and thin-layer chromatography steps, since it is 
well know that PGEz easily undergoes dehydration in 
these conditions [ 141. This experiment confirms that 
the tritium of 4 S [4-3H]NADH is incorporated in 
position 15 S of PGEz by the 15-hydroxy-prostag- 
landin dehydrogenase. 
In conclusion, our data give evidence that the 
hydride transfer catalyzed by the placental 15-hydroxy- 
prostaglandin dehydrogenase is direct and that this 
enzyme should be considered as a B dehydrogenase. 
3.4. Oxidation of the /1.5-3H]PGE2 by the NAD’and Acknowledgements 
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Table 3 
Oxidation of [ 15-3H] PGE, by NAD+and 15-hydroxy-prostaglandin dehydrogenase 
15-Hydroxy- 
prostaglandin 
dehydrogenase 
[15-‘H]PGE, Distribution of radioactivity (dpm) 
and NAD+ 
Aqueous phase PGE, PGA* 
0 t 0 400 000 230 000 
+ + 420 000 33 000 200 000 
Distribution of the radioactivity after incubation and separation of products by 
thin-layer chromatography. 
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